RQM+ launches clinical trial services division

RQM+ has launched a clinical trial services division to complete its full assortment of MedTech contract research organization (CRO) services.

Building upon 40 years of regulatory and quality expertise with a large global team, RQM+ now offers comprehensive laboratory testing, product development, reimbursement strategy and clinical trial services to support the entire product lifecycle for medical devices, digital therapeutics, and diagnostics.

“We have fully evolved our capabilities to become the MedTech partner of choice for clients who want to reduce their commercialization risk by providing all the services needed to launch their products in the market and keep them there,” said CEO Margaret Keegan. “With the strongest regulatory consulting team in the MedTech industry, our trusted experts provide support from the early development stage to commercialization, all within one organization. To deliver the high-quality clinical trials our clients expect, we are delighted to have someone with the depth of expertise that David Novotny brings to lead our trial services business.” Medical Product Outsourcing